Epitopes
AssigneeScancell Limited
InventorsWei Xue, Katherine Wendy Cook, Linda Gillian Durrant, Victoria Anne Brentville
Life of this patent
Estimating the term…
Abstract
The present invention relates to epitopes containing homocitrulline (Hcit) that can be used as targets for cancer immunotherapy. The homocitrullinated T cell epitope has (i) a predicted binding score to MHC class II or class I of <30 using the online IEDB prediction program (http://www.iedb.org/) and (ii) at least 5 consecutive amino acids that form a spiral conformational structure. These modified peptides can be used as vaccines or as targets for T cell receptor (TCR) and adoptive T cell transfer therapies.
Claims15
A homocitrullinated T cell epitope having (i) a predicted binding score to WIC class II or WIC class I of <30 using the online IEDB prediction program (http://www.iedb.org/) and (ii) at least 5 consecutive amino acids that form a spiral conformational structure.
(canceled)
Dependencies are inferred from the claim text.